Immune Pharmaceuticals - Company & Market Research Reports

Immune Pharmaceuticals is a clinical stage biopharmaceutical company that develops novel targeted therapeutics in the immuno-inflammation and immuno-oncology areas. The company's lead product candidate is Bertilimumab, a human monoclonal antibody, which is in Phase II clinical trial for the treatment of ulcerative colitis, bullous pemphigoid, and Crohn's disease. Immune Pharmaceuticals, Inc. was founded in 2010 and is headquartered in New York, New York.

Atopic Dermatitis (Atopic Eczema) - Pipeline Review, H2 2018 - Product Thumbnail Image

Atopic Dermatitis (Atopic Eczema) - Pipeline Review, H2 2018

  • Drug Pipelines
  • 440 Pages
From
Atopic Dermatitis - Pipeline Review, H1 2018 - Product Thumbnail Image

Atopic Dermatitis - Pipeline Review, H1 2018

  • Drug Pipelines
  • 379 Pages
From
Dermatology Therapeutics Drug Development Pipeline Review, 2016 - Product Thumbnail Image

Dermatology Therapeutics Drug Development Pipeline Review, 2016

  • Report
  • 432 Pages
From
Global Autoimmune and Inflammatory Immunomodulators Market 2016-2020 - Product Thumbnail Image

Global Autoimmune and Inflammatory Immunomodulators Market 2016-2020

  • Report
  • 98 Pages
From
 What's Trending in Monoclonal Antibodies (Market by Structure [Chimeric, Humanized], by Target [EGFR, TNF, HER2, CD20,PD-1, Other] and by Disease [Autoimmune, Oncology, Neurological, Other]) - Product Thumbnail Image

What's Trending in Monoclonal Antibodies (Market by Structure [Chimeric, Humanized], by Target [EGFR, TNF, HER2, CD20,PD-1, Other] and by Disease [Autoimmune, Oncology, Neurological, Other])

  • Report
  • 203 Pages
From
Competitor Analysis: Biosimilar & Biosuperior Therapeutic Antibodies - 2016 Update - Product Thumbnail Image

Competitor Analysis: Biosimilar & Biosuperior Therapeutic Antibodies - 2016 Update

  • Report
  • 462 Pages
From
Dermatitis - Pipeline Review, H2 2015 - Product Thumbnail Image

Dermatitis - Pipeline Review, H2 2015

  • Drug Pipelines
  • 445 Pages
From
Psoriasis - Pipeline Review, H2 2018 - Product Thumbnail Image

Psoriasis - Pipeline Review, H2 2018

  • Drug Pipelines
  • 726 Pages
From
Psoriasis - Pipeline Review, H1 2018 - Product Thumbnail Image

Psoriasis - Pipeline Review, H1 2018

  • Drug Pipelines
  • 709 Pages
From
Bullous Pemphigoid Global Clinical Trials Review, H1, 2017 - Product Thumbnail Image

Bullous Pemphigoid Global Clinical Trials Review, H1, 2017

  • Clinical Trials
  • 51 Pages
From
US Transdermal Patch Market & Clinical Trial Insight - Product Thumbnail Image

US Transdermal Patch Market & Clinical Trial Insight

  • Clinical Trials
  • 300 Pages
From
Pemphigus Global Clinical Trials Review, H1, 2018 - Product Thumbnail Image

Pemphigus Global Clinical Trials Review, H1, 2018

  • Clinical Trials
  • 67 Pages
From
Diabetic Neuropathic Pain - Pipeline Review, H2 2016 - Product Thumbnail Image

Diabetic Neuropathic Pain - Pipeline Review, H2 2016

  • Drug Pipelines
  • 95 Pages
From
Diabetic Neuropathic Pain - Pipeline Review, H1 2016 - Product Thumbnail Image

Diabetic Neuropathic Pain - Pipeline Review, H1 2016

  • Drug Pipelines
  • 100 Pages
From
Global Analgesics Market 2016-2020 - Product Thumbnail Image

Global Analgesics Market 2016-2020

  • Report
  • 102 Pages
From
Diabetic Neuropathic Pain - Pipeline Review, H1 2015 - Product Thumbnail Image

Diabetic Neuropathic Pain - Pipeline Review, H1 2015

  • Drug Pipelines
  • 106 Pages
From
Global Transdermal Patch Market & Clinical Pipeline Outlook 2022 - Product Thumbnail Image

Global Transdermal Patch Market & Clinical Pipeline Outlook 2022

  • Report
  • 260 Pages
From
Bullous Pemphigoid - Pipeline Review, H1 2018 - Product Thumbnail Image

Bullous Pemphigoid - Pipeline Review, H1 2018

  • Drug Pipelines
  • 66 Pages
From
Low Back Pain - Pipeline Review, H2 2018 - Product Thumbnail Image

Low Back Pain - Pipeline Review, H2 2018

  • Drug Pipelines
  • 113 Pages
From
Low Back Pain - Pipeline Review, H1 2018 - Product Thumbnail Image

Low Back Pain - Pipeline Review, H1 2018

  • Drug Pipelines
  • 105 Pages
From
Loading Indicator
adroll